Hi, what are you looking for?
Acelyrin said Thursday that has filed for an initial public offering.
The late stage clinical biopharmaceutical company is offering 30 million shares of common stock at a price of $18 each.
It applied to list its shares on the Nasdaq Global Select Market under the symbol SLRN.
The…
Read the full article here
This article was written by Follow Envision Research, aka Lucas Ma, has over 20+ years of investment experience and holds a Masters with in...
Follow Play Earnings CallPlay Earnings Call Riot Platforms, Inc. (RIOT) Discusses Transformational Milestones and Strategic Data Center Expansion January 16, 2026 10:00 AM EST...
This article was written by Follow Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various...
